Ana Victoria Ibarra-Meneses Selected Research

Proteins (Proteins, Gene)

1/2018

Antigenicity of Leishmania-Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination With pCI-neo-LACK Plus Attenuated LACK-Expressing Vaccinia Viruses in Hamsters.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ana Victoria Ibarra-Meneses Research Topics

Disease

9	Leishmaniasis 01/2022 - 01/2017
4	Visceral Leishmaniasis (Kala Azar) 01/2022 - 01/2017
3	Asymptomatic Infections 01/2022 - 05/2019
3	Infections 01/2022 - 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Cutaneous Leishmaniasis 01/2017

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 01/2022 - 01/2018
3	AntigensIBA 01/2022 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
3	VaccinesIBA 01/2022 - 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	ElementsIBA 01/2022
1	ChemokinesIBA 01/2022
1	LigandsIBA 01/2022
1	tetrahydrozoline (Visine)FDA Link 03/2021
1	GenieIBA 03/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Interleukin-2 (IL2)IBA 05/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Immunoglobulin G (IgG)IBA 01/2017
1	N-Glycosyl HydrolasesIBA 01/2017
1	EpitopesIBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2017

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022